Form D · Other

Vivvi, Inc.

New York, NY · CIK 0001757781

Offering snapshot reported May 13, 2025 · SEC filing

Reported sold
$23.4M
Offering amount: $25M
Investors reported
35
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 8, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 13, 2025Initial$23,389,584No comparison35SEC filing
Feb 18, 2022Initial$14,472,171No comparison37SEC filing
Jan 6, 2020Initial$8,004,276No comparison24SEC filing
Nov 1, 2018Initial$2,249,996No comparison27SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-545983

Source: Form D, filed May 13, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Charles Bonello Director, Executive
Charles Bonillo Director, Executive
Alexander Farkas Director
Brian Hirsch Director
Andrew Kaplan Director
Amy Nelson Director
Benjamin Newton Director, Executive
Rick Segal Director
Stefan Szanto Director

Issuer details

Industry: Other (See others in industry)

Address:
205 Hudson Street, 8th Floor
New York, NY, 10013